Lineage, Inc. Common Stock (LINE)vsRe Max Holding (RMAX)
LINE
Lineage, Inc. Common Stock
$35.99
-1.64%
REAL ESTATE · Cap: $8.93B
RMAX
Re Max Holding
$10.70
-3.34%
REAL ESTATE · Cap: $607.91M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 1736% more annual revenue ($5.36B vs $291.60M). RMAX leads profitability with a 2.8% profit margin vs -1.9%. RMAX earns a higher WallStSmart Score of 44/100 (D).
LINE
Hold36
out of 100
Grade: F
RMAX
Hold44
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$35.99
$125.50 discount
Intrinsic value data unavailable for RMAX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Strong operational efficiency at 24.0%
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Moderate valuation
Smaller company, higher risk/reward
ROE of 0.2% — below average capital efficiency
2.8% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : RMAX
The strongest argument for RMAX centers on Price/Book, Operating Margin.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : RMAX
The primary concerns for RMAX are P/E Ratio, Market Cap, Return on Equity. Thin 2.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while RMAX is a value play — different risk/reward profiles.
LINE is growing revenue faster at -0.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RMAX scores higher overall (44/100 vs 36/100). LINE offers better value entry with a 75.9% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Re Max Holding
REAL ESTATE · REAL ESTATE SERVICES · USA
RE / MAX Holdings, Inc. is a franchisor of real estate and mortgage brokerage services in the United States, Canada, and internationally. The company is headquartered in Denver, Colorado.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?